Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Dechra Pharmaceuticals PLC (GB:DPH)
LSE:DPH
Dechra Pharmaceuticals (DPH) Share Price & Analysis
5 Followers
DPH Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range2,446.04p - 4,000.00p
Previous Close3,340p
Volume603.51K
Average Volume (3M)1.18M
Market Cap
£4.18B
Enterprise Value426.58B
Total Cash (Recent Filing)£87.90M
Total Debt (Recent Filing)£511.20M
Price to Earnings (P/E)92.4
Beta0.93
Next Earnings
Sep 04, 2023EPS EstimateN/A
Last Dividend Ex-Date
Mar 09, 2023Dividend Yield
0.45 (0.01%)Share Statistics
EPS (TTM)0.36
Shares Outstanding113,824,190
10 Day Avg. Volume360,330
30 Day Avg. Volume1,182,970
Standard Deviation0.08
R-Squared0.05
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-1415.73
Price to Sales (P/S)1096.02
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
4,220.00pPrice Target Upside15.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
DPH FAQ
What was Dechra Pharmaceuticals PLC’s price range in the past 12 months?
Dechra Pharmaceuticals PLC lowest share price was 2446.04p and its highest was 4000.00p in the past 12 months.
What is Dechra Pharmaceuticals PLC’s market cap?
Currently, no data Available
When is Dechra Pharmaceuticals PLC’s upcoming earnings report date?
Dechra Pharmaceuticals PLC’s upcoming earnings report date is Sep 04, 2023 which is in 94 days.
How were Dechra Pharmaceuticals PLC’s earnings last quarter?
Dechra Pharmaceuticals PLC released its earnings results on Feb 27, 2023. The company reported 0.554p earnings per share for the quarter, beating the consensus estimate of N/A by 0.554p.
Is Dechra Pharmaceuticals PLC overvalued?
According to Wall Street analysts Dechra Pharmaceuticals PLC’s price is currently Undervalued.
Does Dechra Pharmaceuticals PLC pay dividends?
Dechra Pharmaceuticals PLC pays a Annually dividend of 12.5p which represents an annual dividend yield of 1.35%. See more information on Dechra Pharmaceuticals PLC dividends here
What is Dechra Pharmaceuticals PLC’s EPS estimate?
Dechra Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dechra Pharmaceuticals PLC have?
Dechra Pharmaceuticals PLC has 113,884,140 shares outstanding.
What happened to Dechra Pharmaceuticals PLC’s price movement after its last earnings report?
Dechra Pharmaceuticals PLC reported an EPS of 0.554p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.214%.
Which hedge fund is a major shareholder of Dechra Pharmaceuticals PLC?
Currently, no hedge funds are holding shares in GB:DPH
---
Dechra Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
4,220.00p (15.30% Upside)
4,220.00p (15.30% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.83%
12-Months-Change
Fundamentals
Return on Equity
5.42%
Trailing 12-Months
Asset Growth
48.11%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.
---
Top 5 ETFs holding DPH
dbxt FTSE ALL-S Shs -1D- Distribution
$1.30M
Franklin FTSE United Kingdom ETF
$1.04M
SPDR FTSE UK All Share UCITS ETF
$991.24K
SPDR UK All Sh Accum.Shs GBP
$969.44K
Lyxor Core UK Equity All Cap (DR) UCITS ETF
$519.93K
Up to five ETFs with an Outperform Smart Score that hold DPH. The ETFs are listed according to market value of DPH within the ETF
---
Avacta Group plc
―
Advanced Oncotherapy
―
C4X Discovery Holdings
―
EKF Diagnostics Holdings
―
---